KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of YMAB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Y-mAbs Therapeutics Inc. stock price ended at $14.84 on Thursday, after losing 2.94%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 11, 2024 Gain 1.44% PDF

The Y-mAbs Therapeutics Inc. stock price fell by -2.94% on the last day (Thursday, 25th Apr 2024) from $15.29 to $14.84. During the last trading day the stock fluctuated 8.15% from a day low at $14.28 to a day high of $15.44. The price has been going up and down for this period, and there has been a 1.44% gain for the last 2 weeks. Volume has increased on the last day by 194 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 349 thousand shares were bought and sold for approximately $5.18 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.87% during the next 3 months and, with a 90% probability hold a price between $13.07 and $20.48 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

YMAB Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Y-mAbs Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.12 and $15.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -20.60%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Y-mAbs Therapeutics Inc. stock

Y-mAbs Therapeutics Inc. finds support from accumulated volume at $14.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.16 between high and low, or 8.15%. For the last week, the stock has had daily average volatility of 6.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (YMAB) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Y-mAbs Therapeutics Inc. to open at $14.85, and during the day (based on 14 day Average True Range), to move between $13.89 and $15.79, which gives a possible trading interval of +/-$0.95 (+/-6.39%) up or down from last closing price. If Y-mAbs Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.88 (0.27%) than the support at $14.36 (3.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Y-mAbs Therapeutics Inc. stock A Buy?

The Y-mAbs Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Y-mAbs Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.422 Sell Candidate Unchanged

Predicted Opening Price for Y-mAbs Therapeutics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$14.85 ( 0.0979%) $14.84

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for YMAB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.02 7.94 %
R2 15.57 4.94 %
R1 15.30 3.09 %
Current price: 14.84
Support S1 14.41 -2.90 %
S2 14.14 -4.75 %
S3 13.69 -7.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.00 1.08 %
R2 14.89 0.337 %
R1 14.88 0.270 %
Current price 14.84
Support S1 14.36 -3.23%
S2 13.59 -8.42%
S3 11.27 -24.06%

FAQ

What is the symbol for Y-mAbs Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Y-mAbs Therapeutics Inc. is YMAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Y-mAbs Therapeutics Inc. Stock?
The Y-mAbs Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Y-mAbs Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Y-mAbs Therapeutics Inc. Stock?
Y-mAbs Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Y-mAbs Therapeutics Inc. Stock.

What's the current price of Y-mAbs Therapeutics Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Y-mAbs Therapeutics Inc. (YMAB) share was $14.84.

What is the 52-week high and low for Y-mAbs Therapeutics Inc. Stock?
The 52-week high for Y-mAbs Therapeutics Inc. Stock is $20.90 and the 52-week low is $4.60.

What is the market capitalization of Y-mAbs Therapeutics Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Y-mAbs Therapeutics Inc. is 649.652M.

When is the next earnings date for Y-mAbs Therapeutics Inc.?
The upcoming earnings date for Y-mAbs Therapeutics Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics. Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developin... YMAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT